Register entry
- Registered sites
- 2
- Active NDC listings
- 8
- Live patents
- 9
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
Analytical testing2Labelling1Finished drug manufacture1Packaging1
Sites
Registered establishments
2| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Aucta Pharmaceuticals, Inc. | 170 Mount Airy Rd, Basking Ridge, New Jersey (NJ) 07920, United States (USA) | Analytical testing | 3029416323119058320 |
| Aucta Pharmaceuticals, Inc. | 71 Suttons Lane, Piscataway, New Jersey (NJ) 08854, United States (USA) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3015204529016894249 |
Catalogue
Drug listings by form and route
88 active NDC listings: 8 human prescription drug. By marketing category: ANDA 5, NDA 3.
| Dosage form | NDCs |
|---|---|
| capsule, extended release | 3 |
| powder, for solution | 2 |
| granule, for solution | 1 |
| solution | 1 |
| suspension | 1 |
| Route | NDCs |
|---|---|
| oral | 7 |
| respiratory (inhalation) | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| aucta pharmaceuticals, inc. | 8 |
Exclusivity
Patents and exclusivities
9| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 11337943 | MOTPOLY XRlacosamide | product | Jun 2040 |
| 11883374 | MOTPOLY XRlacosamide | product | Jun 2040 |
| 12042474 | MOTPOLY XRlacosamide | product | Jun 2040 |
Catalogue
Marketed products
8| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Arformoterol Tartrate Inhalation Solution | Arformoterol Tartrate | solution, respiratory (inhalation) | 73289-0072ANDA |
| Fosfomycin Tromethamine | Fosfomycin tromethamine | granule, for solution, oral | 73289-0067ANDA |
| MOTPOLY XR | lacosamide | capsule, extended release, oral | 73289-0063NDA |
| MOTPOLY XR | lacosamide | capsule, extended release, oral | 73289-0064NDA |
| MOTPOLY XR | lacosamide | capsule, extended release, oral | 73289-0065NDA |
| PYQUVI | deflazacort | suspension, oral | 73289-0089ANDA |
| ZELVYSIA | SAPROPTERIN DIHYDROCHLORIDE | powder, for solution, oral | 73289-0070ANDA |
| ZELVYSIA | sapropterin dihydrochloride | powder, for solution, oral | 73289-0071ANDA |
Neighbours
Registered in the same town
9- Amneal Pharmaceuticals of New York, LLCPiscataway, NJ
- MSN Laboratories Private Limited,Piscataway, NJ
- Coglate-Palmolive CompanyPiscataway, NJ
- L'Oreal USA Products IncPISCATAWAY, NJ
- Kashiv BioSciences, LLCPiscataway, NJ
- APPCO PHARMA LLCPiscataway, NJ
- Camber Consumer Care IncPiscataway, NJ
- Camber Pharmaceuticals, Inc.PISCATAWAY, NJ
- Medcore llcBasking Ridge, NJ
Compare
Comparable companies in United States
- Deseret Laboratories Incorporated2 sites · 858 NDC
- Padagis Israel Pharmaceuticals Ltd2 sites · 236 NDC
- PureTek Corporation2 sites · 178 NDC
- Cosmax Usa Corporation2 sites · 142 NDC
- Apotheca Company2 sites · 110 NDC
- Nivagen Pharmaceuticals LLC2 sites · 106 NDC
- GOJO Industries, LLC2 sites · 84 NDC
- KVK-TECH, INC.2 sites · 71 NDC
- Revlon Consumer Products Corporation2 sites · 61 NDC
- Samsung Biologics Co., Ltd.2 sites · 57 NDC
Enquiry
Common questions
- Is Aucta Pharmaceuticals, Inc. FDA approved?
- Aucta Pharmaceuticals, Inc. holds 2 FDA-registered establishments in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Aucta Pharmaceuticals, Inc.'s drugs manufactured?
- The FDA register lists Basking Ridge, NJ; Piscataway, NJ. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
- What drugs does Aucta Pharmaceuticals, Inc. make?
- 8 products are listed under Aucta Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as capsule, extended release; powder, for solution; granule, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.